RecruitingPhase 2NCT06864624

Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC

Studying Anorectal malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tang-Du Hospital
Intervention
Sunvozertinib(drug)
Enrollment
27 target
Eligibility
18 years · All sexes
Timeline
20252029

Study locations (3)

Collaborators

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06864624 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation

← Back to all trials